
Fulvenat Injection - Advanced Hormonal Therapy For Breast Cancer Treatment , Blocks Estrogen Action And Stops Cancer Growth
Price:
Get Latest Price
In Stock
Product Specifications
| Salt Composition | Fulvestrant 250 mg |
| Dosage Form | Injection |
| Indication | Breast cancer (hormone receptor-positive metastatic breast cancer in postmenopausal women) |
| Feature | Other, Antineoplastic, estrogen receptor antagonist |
| Ingredients | Other , Fulvestrant |
| Application | Other, Hospital, clinical use for oncology treatment |
| Physical Color/Texture | Other , Clear, colorless to yellowish oily solution |
| Fermentation Smell | Other, Odorless |
| Storage Instructions | Store below 30AdegC, protect from light and do not freeze |
| Shelf Life | 24 months |
| Main Export Market(s) | Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa |
Company Details
Business Type
Exporter, Distributor, Trading Company
Employee Count
10
Establishment
1991
Working Days
Monday To Sunday
GST NO
27AARFP5752B1Z1
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
GST - 27AARFP5752B1Z1
Mumbai, Maharashtra
Accepts only Foreign inquiries
Proprietor
Mr Amith Dhiraj Galaa
Members since
11 Years
Address
12/B, Thacker Industrial Estate, N. M. Joshi Marg, Lower Parel (E), Mumbai, Maharashtra, 400011, India
fulvenat injection in Mumbai
Report incorrect details


































